{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&tablingMemberPrinted.=Adam+Afriyie&max-date=2015-03-13", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&tablingMemberPrinted.=Adam+Afriyie&max-date=2015-03-13", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&tablingMemberPrinted.=Adam+Afriyie&max-date=2015-03-13&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&tablingMemberPrinted.=Adam+Afriyie&_page=0&max-date=2015-03-13", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&tablingMemberPrinted.=Adam+Afriyie&max-date=2015-03-13", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&tablingMemberPrinted.=Adam+Afriyie&max-date=2015-03-13", "items" : [{"_about" : "http://data.parliament.uk/resources/227303", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/227303/answer", "answerText" : {"_value" : "

No such assessment has been made.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-20T14:15:26.337Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Brain Cancer"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effect of a ketogenic diet in treating brain cancer patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1586", "label" : {"_value" : "Biography information for Adam Afriyie"} } , "tablingMemberConstituency" : {"_value" : "Windsor"} , "tablingMemberPrinted" : [{"_value" : "Adam Afriyie"} ], "uin" : "227519"} , {"_about" : "http://data.parliament.uk/resources/227147", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/227147/answer", "answerText" : {"_value" : "

Frimley Park NHS Foundation Trust and Heatherwood and Wexham Park NHS Foundation Trust merged on 1 October 2014 to create Frimley Health NHS Foundation Trust.<\/p>

<\/p>

<\/p>

<\/p>

Progress since the date of the merger is not collected centrally.<\/p>

<\/p>

<\/p>

<\/p>

We have written to Mike Aaronson, Chair of the Frimley Health NHS Foundation Trust informing him of my hon. Friend\u2019s enquiry. He will reply shortly and a copy of the letter will be placed in the Library.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-03-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-19T16:28:08.517Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Frimley Park Hospital NHS Foundation Trust: Heatherwood and Wexham Park Hospitals NHS Foundation Trust"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what progress he has made on the merger of Frimley Park NHS Trust and Heatherwood and Wrexham Park NHS Trust; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1586", "label" : {"_value" : "Biography information for Adam Afriyie"} } , "tablingMemberConstituency" : {"_value" : "Windsor"} , "tablingMemberPrinted" : [{"_value" : "Adam Afriyie"} ], "uin" : "227397"} , {"_about" : "http://data.parliament.uk/resources/227149", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/227149/answer", "answerText" : {"_value" : "

Data is not available on the proportion of National Health Service patients registering interest in participating in clinical trials or the proportion that participate.<\/p>

<\/p>

<\/p>

<\/p>

Recruitment in England to clinical trials hosted by the National Institute for Health Research (NIHR) Clinical Research Network (CRN), and total recruitment in England to all trials and other well-designed studies hosted by the CRN is shown in the following table.<\/p>

<\/p>

<\/p>

<\/p>

<\/p><\/td>

2011-12<\/p><\/td>

2012-13<\/p><\/td>

2013-14<\/p><\/td><\/tr>

Trials<\/p><\/td>

49,372<\/p><\/td>

56,455<\/p><\/td>

60,056<\/p><\/td><\/tr>

All trials and studies<\/p><\/td>

595,540<\/p><\/td>

637,974<\/p><\/td>

604,216<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-19T16:26:22.63Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Clinical Trials"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what proportion of NHS patients registered for clinical trials in (a) 2012, (b) 2013 and (c) 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1586", "label" : {"_value" : "Biography information for Adam Afriyie"} } , "tablingMemberConstituency" : {"_value" : "Windsor"} , "tablingMemberPrinted" : [{"_value" : "Adam Afriyie"} ], "uin" : "227402"} , {"_about" : "http://data.parliament.uk/resources/224467", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/224467/answer", "answerText" : {"_value" : "

The Government is committed to ensuring that patients have access to effective treatments, including those for brain cancers, on terms that represent value to the National Health Service and the taxpayer.<\/p>

<\/p>

<\/p>

<\/p>

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. NICE has recommended the following drugs for brain cancers as treatment options, subject to certain clinical criteria, in its technology appraisal guidance published in June 2007:<\/p>

<\/p>

<\/p>

<\/p>

- temozolomide (Temodal) for the treatment of newly diagnosed glioblastoma multiforme (GBM); and<\/p>

<\/p>

<\/p>

<\/p>

- carmustine (Gliadel) implants, for the treatment of newly diagnosed high-grade glioma.<\/p>

<\/p>

<\/p>

<\/p>

NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance.<\/p>

<\/p>

<\/em><\/p>

<\/p>

Where a drug to treat brain cancer is not routinely available on the NHS, patients may be able to access it through the Cancer Drugs Fund. Bevacizumab (Avastin) is available for the third line treatment of low grade paediatric gliomas through the Fund.<\/p>

<\/p>

<\/p>

<\/p>

We are also commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-09T12:44:29.193Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Brain Cancer: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps the Government has taken to improve brain cancer patients' access to cancer drugs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1586", "label" : {"_value" : "Biography information for Adam Afriyie"} } , "tablingMemberConstituency" : {"_value" : "Windsor"} , "tablingMemberPrinted" : [{"_value" : "Adam Afriyie"} ], "uin" : "225805"} , {"_about" : "http://data.parliament.uk/resources/89677", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/89677/answer", "answerText" : {"_value" : "

<\/p>

The Department is working to support the National Health Service to increase the recovery of costs from overseas visitors and migrants. We aim to recover £500 million annually by the middle of the next Parliament, which will be reinvested into the NHS to support the sustainability of NHS frontline services.<\/p>

<\/p>

<\/p>

<\/p>

The Department published its Implementation Plan on 14 July 2014 at:<\/p>

<\/p>

<\/p>

<\/p>

www.gov.uk/government/publications/recovering-costs-of-nhs-healthcare-from-visitors-and-migrants<\/p>

<\/p>

<\/p>

<\/p>

This sets out how the Department will improve the recovery rates from overseas visitors and migrants over the next year. It announced a number of measures to support these efforts but also laid the foundations for additional areas to be looked at as the programme progresses.<\/p>

<\/p>

<\/p>

As part of the programme the Department is starting a programme of financial incentives to support the NHS in identifying chargeable visitors and migrants using the NHS. These incentives recognise the administrative and financial burdens that can face NHS trusts in the recovery process and aim to counter balance these. The implementation plan provides the full detail of these schemes.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2014-09-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-09-05T13:16:37.5869544Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-08-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: Foreign Nationals"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what recent steps he has taken to ensure that foreign nationals pay for healthcare they receive in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1586", "label" : {"_value" : "Biography information for Adam Afriyie"} } , "tablingMemberConstituency" : {"_value" : "Windsor"} , "tablingMemberPrinted" : [{"_value" : "Adam Afriyie"} ], "uin" : "207406"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }